Loading viewer...
investor_presentation
Format: PDF investor_presentation
Marinomed Biotech AG is an Austrian biopharmaceutical company listed on the Vienna Stock Exchange, operating across virology and immunology segments. The company develops OTC products including Carragelose and Marinosolv, plus proprietary solubilization technology partnerships. Key milestones include its 2019 IPO, 2021 Solv4U launch, and 2022 partnership with Procter & Gamble.
investor_presentation
13 Pages
Tacoma Power